p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism

Jonuelle Acosta1,2, Qinglan Li1, Nelson F Freeburg1,2

  • 1Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Nature Communications
|July 21, 2023
PubMed

Insights

Restoring tumor suppressor p53 in small cell lung cancer (SCLC) triggers cell death, but the mechanism depends on tumor subtype. Cyclophilins control p53-induced necrosis, offering potential therapeutic targets for SCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor is crucial for preventing cancer but its role in small cell lung cancer (SCLC) is unclear.
  • p53 is frequently mutated in SCLC, yet its precise function in tumor suppression within this context remains largely unknown.

Purpose of the Study:

  • To investigate how p53 mediates tumor suppression in SCLC.
  • To explore the heterogeneity of p53's effects and identify molecular mechanisms driving cell death in SCLC.

Main Methods:

  • Utilized a conditional mouse model of SCLC with regulated p53 expression.
  • Analyzed tumor subtype heterogeneity and identified cyclophilins as key regulators.
  • Investigated the impact of cyclophilin inhibition on p53-mediated cell death.

Main Results:

  • SCLC tumors require p53 inactivation but exhibit heterogeneity in response to p53 reactivation.
  • p53 reactivation induces either senescence or necrosis depending on the tumor subtype.
  • Cyclophilins are essential for a p53-induced transcriptional program leading to necrosis in specific SCLC subtypes.
  • Inhibiting cyclophilin activity suppresses p53-mediated necrosis by modulating p53 transcriptional output.

Conclusions:

  • Intertumoral heterogeneity in SCLC dictates the cellular response to p53 restoration.
  • A cyclophilin-dependent mechanism regulates p53-induced necrosis in SCLC.
  • Targeting cyclophilins presents a potential therapeutic strategy for treating SCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K